STEPPC (Lung Cancer)
What is the Purpose of this Study?
If you choose to join the study, you will:
- Fill out study questionnaires about your health and how you are feeling
- Be randomly assigned (like a coin flip) to one of the 2 study groups
-- One group will receive Early Integrated Palliative Care (participants will see palliative care every 4 weeks)
-- The other group will receive Stepped Palliative Care (participants will not see palliative care after their first appointment unless admitted to the hospital, or their condition gets worse)
- Fill out study questionnaires about your health and how you are feeling
- Be randomly assigned (like a coin flip) to one of the 2 study groups
-- One group will receive Early Integrated Palliative Care (participants will see palliative care every 4 weeks)
-- The other group will receive Stepped Palliative Care (participants will not see palliative care after their first appointment unless admitted to the hospital, or their condition gets worse)
What is the Condition Being Studied?
Advanced Lung Cancer
Who Can Participate in this Study?
Adults ages 18+ who:
- Are diagnosed with advanced NSCLC, small cell lung cancer, or mesothelioma
- Are being treated with non-curative intent
- Were informed of advanced disease within the prior 12 weeks
- Can read and speak in English or Spanish
- Get their primary cancer care at Duke University Hospital
For more information about who can join this study, please contact the study team at isaac.oyediran@duke.edu.
Age Group
Adults
Participating Institutions
What is Involved?
We are doing this study to find out if it is better for you to see palliative care regularly throughout your illness or only if you are having an issue with your health.
Study Details
Full Title
Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer
Principal Investigator
Protocol Number
IRB:
PRO00092124
NCT:
NCT03337399
ClinicalTrials.gov
View on ClinicalTrials.gov